Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just one stent, which is deployed via a thumbwheel delivery system.
A Cook press release states that Zilver PTX is the world’s first drug-eluting stent for the superficial femoral artery and “has been proven over five years to reduce restenosis and reinterventions by nearly half compared to Zilver bare-metal stents and percutaneous transluminal angioplasty.”
